期刊文献+

替加环素联合异帕米星治疗多重耐药鲍曼不动杆菌肺炎的效果观察 被引量:3

在线阅读 下载PDF
导出
摘要 目的观察替加环素联合异帕米星治疗多重耐药鲍曼不动杆菌肺炎的临床效果。方法选择沈丘县人民医院2012年9月至2014年9月收治的47例多重耐药鲍曼不动杆菌肺炎患者,根据随机的原则将患者分为治疗组24例与对照组23例,治疗组患者给予替加环素联合异帕米星治疗,对照组给予头孢哌酮舒巴坦治疗,药物连续使用7~14 d,观察两组患者的临床疗效、细菌清除率及治疗期间不良反应。结果治疗后,两组临床有效率、细菌清除率差异均有统计学意义(P<0.05)。两组不良反应发生率差异无统计学意义(P>0.05)。结论替加环素联合异帕米星治疗多重耐药鲍曼不动杆菌肺炎疗效好,安全性高,值得临床推广应用。
作者 王俊锋
出处 《河南医学研究》 CAS 2015年第9期106-107,共2页 Henan Medical Research
  • 相关文献

参考文献2

  • 1Buccoliero G,Morelli E,Lonero G,Romanelli C,Resta F,Pisconti S.Rapid spread of multiresistant Acinetobacter baumannii isolates in intensive care units (ICUs) and in vitro activity of colistin and tigecycline. Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive . 2013
  • 2Suárez OR,Espinoza LD,Ponce PA,et al.Pancreatitisprobably induced by tigecycline:a report of a case. Med Int Mex . 2010

同被引文献56

  • 1Garnacho-Montero J, Amaya-Villar R. Multiresistant Acinetobacter baumannii infections: epidemiology and management[J]. Curt Opin Infect Dis, 2010, 23(4): 332-339.
  • 2Karageorgopoulos D E, Falagas M E. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections[J]. Lancet Infect Dis, 2008, 8(12): 751-762.
  • 3Wang L F, Li J L, Ma W H, et al. Drug resistance analysis of bacterial strains isolated from burn patients[J]. Gen Mol Res Gmr, 2014, 13(4): 9727-9734.
  • 4Chopra T, Marchaim D, Awali R A, et al. Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes[J]. Antimicrob Agents Chemother, 2013, 57(12): 6270-6275.
  • 5Rose W E, Rybak M J. Tigecycline: first of a new class of antimicrobial agents[J]. Pharmacotherapy, 2006, 26(8): 1099-1110.
  • 6Karageorgopoulos D E, Kelesidis T, Kelesidis I, et al Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infectionsa review of the scientific evidence[J]. J Antimicrob Chemother, 2008, 62(I): 45-55.
  • 7Guner R, Hasanoglu I, Keske S, et al. Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy[J]. Infection, 2011, 39(6): 515-518.
  • 8Gallagher J C, Rouse H M. Tigecycline for the treatment of Aeinetobaeter infections: a case series[J]. Ann Pharmacother, 2008, 42(9): 1188-1194.
  • 9Wells G A, Shea B, O'Connell D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses[EB/OL]. 2012. Available at: http: //www. ohri. ca/programs/clinical_epidemiology/oxford. asp[accessed 02.08. 12].
  • 10Poulakou G, Kontopidou F V, Paramythiotou E, et al. Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens[J]. J Infect, 2009, 58(4): 273-284.

引证文献3

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部